-
Diagnostics World | There are more cases of cancer in the U.S. than ever before. Over 2 million new cases are expected to be diagnosed in 2025 alone, and cancer incidence is on the rise in 6 of the 10 most common cancers. Delivering speedy, accurate diagnoses and treatment for a growing pool of cancer patients is a daunting challenge for today’s clinicians.
Oct 10, 2025
-
Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice
Oct 1, 2025
-
Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer.
Sep 30, 2025
-
Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.
Sep 25, 2025
-
Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.
Sep 24, 2025
-
Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected.
Sep 18, 2025
-
Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.
Sep 17, 2025
-
Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.
Sep 16, 2025
-
Diagnostics World | A clinical case study from Qure.ai and Hacettepe University, Turkey, delivered at the IASLC World Conference on Lung Cancer 2025 in Barcelona, shows that Artificial Intelligence (AI) can detect potentially malignant pulmonary nodules on routine chest X-rays, even when the imaging was ordered for unrelated, non-respiratory conditions.
Sep 11, 2025
-
Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.
Sep 9, 2025
-
Diagnostics World | In a lively matchup between clinical microbiology experts at the recent Next-Generation Dx Summit, onlookers already predisposed to believing artificial intelligence (AI) would not be replacing conventional microbiology and infectious disease testing in the next 10 years were further swayed toward dismissing the possibility. It perhaps helped that the deciding vote on the debate came immediately after the person arguing mightily about the inevitability of an AI takeover himself switched from the affirmative to the negative position.
Sep 4, 2025
-
Diagnostics World | An assortment of “hot-button issues” in point-of-care testing (POCT) remain to be sorted out amid rising patient demand for access to rapid and reliable tests results, mounting financial pressures on healthcare systems, and ongoing concerns about the setting and timing of testing to reap the most clinical benefits. Having actionable results, improving connections to care, and balancing patient anonymity with public health reporting in sexually transmitted infection (STI) testing are among the current topics of dialogue, as highlighted during the Next-Generation Dx Summit held last month.
Sep 3, 2025
-
Diagnostics World | When it comes to disease diagnostics, every missed genetic variant represents a delay in diagnosis—and often in treatment. Researchers at Pacific Biosciences (PacBio) developed a new genomic benchmark that could help close those diagnostic gaps, offering more accurate detection of genetic variants.
Sep 2, 2025
-
Diagnostics World | Strand Therapeutics will advance their pipeline of STX-001, a programmable mRNA therapy that expresses the cytokine interleukin-12 (IL-12) directly from the tumor microenvironment; Jocasta Therapeutics plan to further develop a - Klotho, a protein therapeutic targeting cognitive decline in neurodegenerative diseases; and more.
Aug 27, 2025
-
Diagnostics World | Roche announced the US Food and Drug Administration (FDA) 510(k) clearance for the cobas Respiratory 4-flex; Dana-Farber Cancer Institute researchers have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma; and more.
Aug 26, 2025
-
Diagnostics World | Earlier this month, Boston Children’s Hospital, Broad Clinical Labs, and Dana-Farber Cancer Institute announced the formation of a collaborative clinical research and testing initiative, Boston Research in Innovative Genomics for Hematologic and Tumor Sequencing (BrightSeq).
Aug 21, 2025
-
Diagnostics World | Efforts to couple patient-level data with machine learning (ML) are going to accelerate “100-plus-fold” over the next decade, dramatically improving evidence-based decision-making and demonstrably improving patient care. In the diagnostics field, supervised learning that leverages classification represents the bulk of this work currently and may even suggest the algorithms best suited to the task at hand.
Aug 20, 2025
-
Diagnostics World | Ultima Genomics published updates on the single-nucleotide variant (SNV) detection capabilities of its ppmSeq technology and demonstrated ctDNA detection limits for ppmSeq, which extend beyond the limits of currently available minimal residual disease assays.
Aug 19, 2025
-
Diagnostics World | With the advent of large language models (LLMs), expert human abstractors are meeting their match when it comes to accurately identifying cancer progression events from electronic health records (EHRs). That’s one of the big surprises emerging from a study presented by Aaron Cohen, M.D., a practicing oncologist and head of oncology research at Flatiron Health, at a recent artificial intelligence and machine learning conference of the American Association for Cancer Research.
Aug 14, 2025
-
Diagnostics World | Like a smartphone housing many software applications, a multi-purpose platform looks to be the launchpad for a potentially huge number of medical devices. The Openwater system, under development for nearly a decade, holds promise in noninvasively diagnosing and treating disease using infrared light and low-intensity focused ultrasound (LIFU).
Aug 12, 2025